Compliance

Finanssivalvonta is calling the updated principles “more precise” than before.

New pharmaceutical rules aim to expand medicine access, strengthen supply security, and reshape incentives for EU innovation.

Key personnel moves across the regulated industries that we cover.

FCA prudential requirements include an obligation for firms to perform an overall risk assessment.

The Australian Securities and Investments Commission’s latest actions and news.

CMS finalized a mandatory Medicare Part B payment model using pricing benchmarks to test lower drug costs while maintaining care quality.

The program addresses longstanding challenges in clinical development, where bringing a new drug or biologic to market can take over a decade.

The FDA is considering changing to its tobacco product review framework as industry groups challenge the agency’s 2021 PMTA rule in court.